Long-Term Survival Rate for Moroccan Patients with Differentiated Thyroid Cancer
Hajar Tabiti1, Amal Guensi1,2, Karima Bendahhou3
1Laboratory of Cellular and Molecular Inflammatory, Degenerative and Oncologic Pathophysiology, Hassan II University Casablanca, Morocco.
Asian Pacific Journal of Cancer Prevention : APJCP
|March 29, 2025
Summary
This study found that Moroccan patients with differentiated thyroid cancer (DTC) have good survival rates, similar to international data. Key factors like male gender, older age, and tumor characteristics significantly impact long-term outcomes.
Area of Science:
- Endocrinology
- Oncology
- Public Health
Background:
- Differentiated thyroid cancer (DTC) of follicular origin generally has a good prognosis.
- However, overall survival is influenced by various factors.
- This study specifically examines survival rates in Moroccan patients.
Purpose of the Study:
- To analyze five-year and ten-year overall survival rates in follicular differentiated thyroid cancer (DTC).
- To identify independent factors influencing survival in Moroccan patients with DTC.
Main Methods:
- Retrospective cohort study of 1366 patients diagnosed between 2004 and 2012.
- Kaplan-Meier method used to calculate survival rates.
- Log-rank test employed to compare survival based on various factors.
Main Results:
- Five-year survival rate was 94%, and ten-year survival rate was 91%.
- Factors reducing survival include male gender, age >55, tumor size >4 cm, vascular invasion, lymph node invasion, distant metastases, and advanced stage.
- Elevated postoperative thyroglobulin (Tg) and post-radioiodine therapy levels (>10 ng/ml) were also associated with reduced survival.
Conclusions:
- Overall survival rates for Moroccan DTC patients align with international literature.
- Survival is significantly influenced by patient demographics (age, gender), tumor characteristics (histology, size, invasion), and treatment response (Tg levels, RAI therapy).
- Disease stage and risk group are critical determinants of overall survival.
Related Concept Videos
Cancer Survival Analysis
291
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
291
Actuarial Approach
39
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
39


